Results 41 to 50 of about 342,314 (174)

Threshold Ring Signatures and Applications to Ad-hoc Groups [PDF]

, 2002
In this paper, we investigate the recent paradigm for group signatures proposed by Rivest et al. at Asiacrypt '01. We first improve on their ring signature paradigm by showing that it holds under a strictly weaker assumption, namely the random oracle model rather than the ideal cipher.
Emmanuel Bresson, Jacques Stern, Michael Szydlo   +2 more
openaire   +1 more source

Faster threshold-SM2 with identifiable abort and non-interactive online signing

Cybersecurity
Threshold signatures are essential for fault-tolerant applications among groups of users, such as in blockchain transactions. SM2 is a digital signature standard in China and ISO, yet its threshold variant is less developed compared to international ...
Yunlv Lv, Rui Zhang, Yang Tao, Zeshuo Zhu   +3 more
doaj   +1 more source

Novel pyroptosis-immune-related lncRNA signature exhibits a distinct immune cell infiltration landscape in breast cancer

Frontiers in Immunology
IntroductionThis study investigated pyroptosis- and immunity-related long non-coding RNAs (lncRNAs) to identify promising therapeutic targets for breast cancer (BC), and constructed lncRNA signatures to determine the prognosis and immunotherapy responses
Dedi Kong, Dedi Kong, Hongju Cheng, Meihong Wang   +3 more
doaj   +1 more source

An acquisition account of genomic islands based on genome signature comparisons

BMC Genomics, 2005
Background Recent analyses of prokaryotic genome sequences have demonstrated the important force horizontal gene transfer constitutes in genome evolution.
Luyf ACM, Thygesen HH, Bart A, van Passel MWJ, van Kampen AHC, van der Ende A   +5 more
doaj   +1 more source

A novel platelets-related gene signature for predicting prognosis, immune features and drug sensitivity in gastric cancer

Frontiers in Immunology
BackgroundPlatelets can dynamically regulate tumor development and progression. Nevertheless, research on the predictive value and specific roles of platelets in gastric cancer (GC) is limited.
Qun Li, Cheng Zhang, Yulin Ren, Lei Qiao, Shuning Xu, Ke Li, Ying Liu   +6 more
doaj   +1 more source

Functional connectivity study on visually evoked auditory response based on high-density electroencephalography

Frontiers in Neuroscience
AimThis study aimed to investigate the brain activity involved in visually evoked auditory response (vEAR) using high-density electroencephalography (EEG) and explore the differences in connections between visual and auditory cortex.MethodsThirty-seven ...
Ning Jia, Yueting Feng, Kun Han
doaj   +1 more source

Threshold Signatures, Multisignatures and Blind Signatures Based on the Gap-Diffie-Hellman-Group Signature Scheme [PDF]

, 2002
We propose a robust proactive threshold signature scheme, a multisignature scheme and a blind signature scheme which work in any Gap Diffie-Hellman (GDH) group (where the Computational Diffie-Hellman problem is hard but the Decisional Diffie-Hellman problem is easy).
openaire   +1 more source

miRNA Signature and its Clinicopathological Association in Colorectal Cancer: A Cross-sectional Study [PDF]

Journal of Clinical and Diagnostic Research
Introduction: Colorectal Cancer (CRC) is a significant health problem worldwide, with more than 70,000 new cancer cases recorded in India in 2020. A better understanding of CRC prognosis is needed.
Ipseet Mishra, Sudipta Naskar
doaj   +1 more source

Treatment failure and drug resistance in HIV‐positive patients on tenofovir‐based first‐line antiretroviral therapy in western Kenya

Journal of the International AIDS Society, 2016
Introduction Tenofovir‐based first‐line antiretroviral therapy (ART) is recommended globally. To evaluate the impact of its incorporation into the World Health Organization (WHO) guidelines, we examined treatment failure and drug resistance among a ...
Katherine Brooks, Lameck Diero, Allison DeLong, Maya Balamane, Marissa Reitsma, Emmanuel Kemboi, Millicent Orido, Wilfred Emonyi, Mia Coetzer, Joseph Hogan, Rami Kantor   +10 more
doaj   +1 more source

A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis

Frontiers in Immunology
BackgroundCurrent guidelines to treat atopic dermatitis (AD) overlook disease heterogeneity, limiting personalized care. This study assessed NuGel, a topical GPCR19 agonist, for efficacy, safety, and predictive baseline biomarkers in AD patients ...
Gyeong Ho Baek, Bo Ri Kim, Bo Ri Kim, Jung-Won Shin, Chang Hun Huh, Jungjoong Hwang, Sungmin Ko, Siwon Kim, Pil-Su Ho, Kyu-Han Kim, Chun Wook Park, Seong Jun Seo, Chang-Ook Park, Dongyoon Shin, Yeongshin Kim, Yeongshin Kim, Youngsoo Kim, Youngsoo Kim, Seung-Yong Seong, Seung-Yong Seong, Seung-Yong Seong, Seung-Yong Seong, Jung-Im Na, Jung-Im Na   +23 more
doaj   +1 more source